Journal Selection & Manuscript Polishing Services
Medicine
Medicine
Back to journal directory
Review Cycle Records
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
165
days
KDM6A suppresses proliferation and epithelial–mesenchymal transition in prostate cancer cells
AuthorsYixiu Ni; Yijia Lin; Wankun Wang; Yizhong Bao; Jun Chen
AffiliationsDepartment of Urology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
63
days
miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression
AuthorsLei Wang; Huan Yang; Jingyue Wang
AffiliationsDepartment of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China; Department of Urology, General Hospital of Central Theater Command of Chinese People's Liberation Army, Wuhan, China; Department of Urology, Wuhan No. 9 Hospital, Wuhan, China
97
days
Evaluation, etiology, and management of gross hematuria following radical cystectomy and orthotopic neobladder
AuthorsMazyar Zahir; Daniel I. Sanford; Chirag Doshi; Muhannad Alsyouf; Sanam Ladi-Seyedian; Kevin Wayne; Michael Basin; Alireza Ghoreifi; Anne Schuckman; Hooman Djaladat; Siamak Daneshmand
AffiliationsUSC Department of Urology, USC/Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA
124
days
Reassessing the role of segmental ureterectomy in upper tract urothelial carcinoma: Functional durability and propensity-matched oncological outcomes
AuthorsRinat Lasmanovich; Oleksandr Chepeliuk; Orel Hemo; May Fihman; Asaf Shvero; Nir Kleinmann; Eddie Fridman; Orith Portnoy; Menachem Laufer; Dorit E. Zilberman; Barak Rosenzweig; Zohar A. Dotan
AffiliationsGray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv, Israel; Department of Urology, Sheba Medical Center, Ramat Gan, Israel; Department of Pathology, Sheba Medical Center, Ramat Gan, Israel; Department of Diagnosis Radiology, Sheba Medical Center, Ramat Gan, Israel
155
days
Intravesical recurrence is associated with increased Treg and exhausted CD8+ T cells in upper tract urothelial carcinoma
AuthorsDaisuke Ito; Tokiyoshi Tanegashima; Genshiro Fukuchi; Satoshi Kobayashi; Takashi Matsumoto; Masaki Shiota; Genki Okumura; Kota Itahashi; Yoshinao Oda; Shohei Koyama; Masatoshi Eto
AffiliationsDivision of Cancer Immunology, Research Institute/Exploratory Oncology Research & Clinical Trial Center (EPOC), National Cancer Center Japan, Tokyo, Japan; Department of Urology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; Department of Immunogenomic Medicine, Research Institute, National Cancer Center Japan, Tokyo, Japan
67
days
Defining a hilar “danger zone” to guide surgical decision-making in T1 renal cell carcinoma
AuthorsZihao Li; Li Wang; Chunzhi Qi; Hongliang Li; Tie Chong; Zhenlong Wang
AffiliationsThe Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China
127
days
Biopsy Gleason pattern 4 burden refines preoperative risk stratification in prostate cancer
AuthorsTheodoros Karanikolas; Austin Freedman; Jonah Tripp; Samuel Yim; Morgan Joseph; Pedro Maria; Ahmed Aboumohamed; Alexander Sankin; Ilir Agalliu; Stephen Reese; Kara Watts
AffiliationsDepartment of Urology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY; Albert Einstein College of Medicine, Bronx, NY; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY
72
days
Use of pelvic lymph node dissection among men undergoing radical prostatectomy in the US: Population-based analysis between 2010 and 2020
AuthorsHriday P. Bhambhvani; Gal Wald; Anjile An; Neal Patel; Daniel A. Barocas; Kevin H. Kensler; Myles M. Reed; David M. Nanus; Rulla Tamimi; Jonathan E. Shoag; Bashir Al Hussein Al Awamlh
AffiliationsDepartment of Urology, Weill Cornell Medicine, New York, NY; Department of Population Health Sciences, Weill Cornell Medicine, New York, NY; Department of Urology, Vanderbilt University Medical Center, Nashville, TN; Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY; Department of Urology, Case Western Reserve University School of Medicine, Cleveland, OH
90
days
Second primary cancer risk after penile squamous cell carcinoma: A population-based study
AuthorsHue T.T. Tran; Frank Z. Jing; Duc L. Van; Raslina Shrestha; Granville L. Lloyd; Clark C. Otley; Daniel S. Childs; Giang H. Nguyen
AffiliationsDepartment of Dermatology, Mayo Clinic, Rochester, MN; Department of Surgery, Section of Urology, CU Anschutz School of Medicine, Aurora, CO; Department of Surgery, Section of Robotic Surgery, Rocky Mountain Regional VA Hospital, Aurora, CO; Division of Dermatology Surgery, Department of Dermatology, Mayo Clinic, Rochester, MN; Department of Medical Oncology, Mayo Clinic, Rochester, MN
145
days
Impact of divergent differentiation and histological subtypes on oncologic outcomes in patients treated with radical nephroureterectomy for upper tract urothelial carcinoma
AuthorsMaximilian Pallauf; Stephan Brönimann; Sean A. Fletcher; Michael E. Rezaee; David J. McConkey; Aaron M. Potretzke; Stephen A. Boorjian; Morgan Rouprêt; Hooman Djaladat; Alireza Ghoreifi; Francesco Soria; Riccardo Campi; Salvatore Granata; Zine-Eddine Khene; Eiji Kikuchi; Michael Rink; Markus von Deimling; Kazutoshi Fujita; David D’Andrea; Shahrokh F. Shariat; Joost Boormans; Benjamin Pradere; Nirmish Singla
AffiliationsThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Urology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria; Department of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Urology, Mayo Clinic, Rochester, MN; Department of Urology, Sorbonne University, GRC 5 Predictive Onco-Uro, AP-HP, Pitie-Salpetriere Hospital, Paris, France; Norris Comprehensive Cancer Center, Institute of Urology, University of Southern California, Los Angeles, CA; Division of Urology, Department of Surgical Sciences, AOU città della Salute e della Scienza di Torino, Torino School of Medicine, Torino, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy; Department of Oncology, Unit of Urology and Renal Transplantation, Careggi University Hospital, Florence, Italy; Department of Urology, University of Rennes, Rennes, France; Department of Urology, St. Marianna University School of Medicine, Kanagawa, Japan; Department of Urology, Marienkrankenhaus Hamburg, Hamburg, Germany; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Kindai University Faculty of Medicine, Osaka, Japan; Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan; Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria; Department of Urology, Weill Cornell Medical College, New York, NY; Department of Urology, University of Texas Southwestern, Dallas, TX; Department of Urology, Second Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Urology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands; Department of Urology UROSUD, La Croix du Sud Hospital, Quint-Fonsegrives, France
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days